The medical journal The Lancet published on Friday that the Russian vaccine Sputnik V, developed by the Gamaleya Institute in Moscow, does generate an immune response against covid-19.
The vaccine is currently in phase 3 clinical trials.
Study reveals new advance of Russian vaccine
2020-09-04T21:36:18.032Z
The medical journal The Lancet published on Friday that the Russian vaccine Sputnik V, developed by the Gamaleya Institute in Moscow, does generate an immune response against covid-19. The vaccine is ...